Tuesday 15 January | |
Boohoo Group | Trading Statement |
Gym Group | Trading Statement |
Hays | Trading Statement |
Mears Group | Trading Statement |
Games Workshop Group | Half Year Results |
Persimmon | Trading Statement |
Watkin Jones | Full Year Results |
Big Yellow | Trading Statement |
Ashmore Group | Trading Statement |
Provident Financial | Trading Statement |
Spire Healthcare Group | Trading Statement |
Ophir Energy | Trading Statement |
Wednesday 16 January | |
Tullow Oil | Trading Statement |
Bovis Homes Group | Trading Statement |
Cineworld group | Trading Statement |
City of London Investment Group | Trading Statement |
Diploma | Trading Statement |
Hochschild Mining | Full Year Production |
Pearson | Trading Statement |
Secure Trust Bank | Trading Statement |
Headlam Group | Trading Statement |
Energean Oil & Gas | Trading Statement |
Saga | Trading Statement |
Thursday 17 January | |
Ibstock | Trading Statement |
Whitbread | Q3 Results |
Game Digital | Trading Statement |
Premier Foods | Q3 Results |
4imprint Group | Trading Statement |
Associated British Foods | Q1 Results |
Chemring Group | Full Year Results |
Experian | Q3 Results |
N Brown Group | Q3 Results |
SSP Group | Q1 Results |
Sage Group | Q1 Results |
Ten Entertainment | Trading Statement |
GVC Holdings | Trading Statement |
Rio Tinto | Q4 Operations Review (at 2130 GMT) |
Friday 18 January | |
Bakkavor | Trading Statement |
Record | Trading Statement |
Henry Boot | Trading Statement |
Monday 21 January | |
Premier Veterinary Group | Full Year Results |
William Hill | Trading Statement |
Alliance Pharma | Trading Statement |
Alliance Pharma expects no profit growth in 2024
(Sharecast News) - Consumer healthcare group Alliance Pharma has said that 2023 results will be in line with market expectations but said that profits are unlikely to grow this year due to increased investment in sales and marketing.
Read more